Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
365.90
172.45
324.94
356.14
345.98
137.41
367.84
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
365.90
172.45
324.94
356.14
345.98
137.41
367.84
Raw Material Cost
53.32
29.34
46.08
47.92
41.84
22.28
35.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.35
0.82
0.82
0.93
1.12
1.41
Selling and Distribution Expenses
170.78
95.04
215.08
188.74
176.84
78.21
247.21
Other Expenses
1.35
1.36
2.43
1.71
2.19
1.69
3.08
Total Expenditure (Excl Depreciation)
237.61
138.28
286.33
254.56
241.48
118.52
314.69
Operating Profit (PBDIT) excl Other Income
128.3
34.2
38.6
101.6
104.5
18.9
53.099999999999994
Other Income
4.50
2.22
10.41
4.45
4.19
2.26
4.77
Operating Profit (PBDIT)
149.42
50.73
67.67
120.18
125.62
42.12
70.76
Interest
0.00
0.35
0.82
0.82
0.93
1.12
1.41
Exceptional Items
2.66
1.90
-5.47
0.00
1.79
0.11
-51.72
Gross Profit (PBDT)
312.58
143.12
278.86
308.23
304.14
115.13
332.54
Depreciation
22.74
22.74
23.21
23.21
21.05
21.05
13.04
Profit Before Tax
129.34
29.54
38.16
96.16
105.44
20.06
4.59
Tax
15.55
2.18
7.30
21.57
11.63
-0.65
11.84
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
113.79
27.36
30.79
74.59
93.81
20.71
-7.25
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
113.79
27.36
30.79
74.59
93.81
20.71
-7.25
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
113.79
27.36
30.79
74.59
93.81
20.71
-7.25
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,613.64
3,564.82
3,537.46
3,506.67
3,432.08
3,468.22
3,447.51
Earnings per share (EPS)
0.88
0.21
0.24
0.57
0.72
0.16
-0.06
Diluted Earnings per share
0.88
0.21
0.24
0.57
0.72
0.16
-0.06
Operating Profit Margin (Excl OI)
33.39%
14.94%
10.48%
25.98%
29.01%
13.69%
14.39%
Gross Profit Margin
41.56%
30.32%
18.89%
33.52%
36.56%
29.92%
4.79%
PAT Margin
31.1%
15.87%
9.47%
20.94%
27.12%
15.07%
-1.97%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 5.75% vs -18.76% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 21.32% vs -40.29% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 19.36% vs -40.26% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -100.00% vs -30.77% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Chengdu Kanghua Biological Products Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
365.90
0
365.90
Other Operating Income
0.00
0.00
0.00
Total Operating income
365.90
0
365.90
Raw Material Cost
53.32
0
53.32
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
170.78
0
170.78
Other Expenses
1.35
0.00
1.35
Total Expenditure (Excl Depreciation)
237.61
0
237.61
Operating Profit (PBDIT) excl Other Income
128.29
0.00
128.29
Other Income
4.50
0
4.50
Operating Profit (PBDIT)
149.42
0
149.42
Interest
0.00
0
0.00
Exceptional Items
2.66
0
2.66
Gross Profit (PBDT)
312.58
0
312.58
Depreciation
22.74
0
22.74
Profit Before Tax
129.34
0
129.34
Tax
15.55
0
15.55
Provisions and contingencies
0
0
0.00
Profit After Tax
113.79
0
113.79
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
113.79
0
113.79
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
113.79
0
113.79
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,613.64
0
3,613.64
Earnings per share (EPS)
0.88
0
0.88
Diluted Earnings per share
0.88
0
0.88
Operating Profit Margin (Excl OI)
33.39%
0%
0.00
33.39%
Gross Profit Margin
41.56%
0%
0.00
41.56%
PAT Margin
31.10%
0%
0.00
31.10%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 36.59 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 112.12% vs -46.91% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 5.75% vs -18.76% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 11.38 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 315.33% vs -11.04% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 21.32% vs -40.29% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.49 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 198.76% vs -15.36% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 19.36% vs -40.26% in Jun 2025
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 33.39%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
